A detailed history of Parkside Financial Bank & Trust transactions in Haleon PLC stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 233 shares of HLN stock, worth $2,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
233
Previous 150 55.33%
Holding current value
$2,260
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$8.32 - $10.7 $690 - $888
83 Added 55.33%
233 $2,000
Q1 2024

May 01, 2024

SELL
$8.02 - $8.67 $2,406 - $2,601
-300 Reduced 66.67%
150 $1,000
Q4 2023

Feb 01, 2024

BUY
$7.78 - $8.62 $1,167 - $1,292
150 Added 50.0%
450 $3,000
Q2 2023

Aug 15, 2023

SELL
$8.04 - $9.0 $1,607 - $1,800
-200 Reduced 40.0%
300 $2,000
Q1 2023

May 04, 2023

BUY
$7.57 - $8.37 $1,514 - $1,673
200 Added 66.67%
500 $4,000
Q4 2022

Feb 13, 2023

BUY
$5.96 - $8.06 $1,788 - $2,418
300 New
300 $2,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.